Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with
Insight Pharmaceuticals recalls Clear Eyes Redness Relief eye drops due to lack of assurance of sterility. Affected lots may cause eye infections. Consumers should stop using and contact the company.
Lower-risk recall
Lack of Assurance of Sterility
What happened, in plain English
Insight Pharmaceuticals is recalling Clear Eyes Redness Relief eye drops because they may not be sterile. Using these drops could lead to eye infections, especially if the product is not properly cleaned or handled. Read more at govinfonow.com/recall/1287564-clear-eyes-eye-drops-recall-lack-of-sterility-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/1287564-clear-eyes-eye-drops-recall-lack-of-sterility-risk · Published October 6, 2026 · Updated October 6, 2026 · FDA enforcement record: FDA #D-0871-2026
Cite this page
“Clear Eyes Eye Drops Recall: Lack of Sterility Risk.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/1287564-clear-eyes-eye-drops-recall-lack-of-sterility-risk. Based on FDA recall #D-0871-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0871-2026%22&limit=1).
Why it’s dangerous
The eye drops may not be sterile, which means they could contain harmful bacteria or other contaminants. This risk is especially concerning for people with eye conditions or weakened immune systems, as it can lead to infections.
Who’s affected
People who own or use Clear Eyes Redness Relief eye drops with the specific lot numbers and expiration dates listed in the recall notice are affected. Those with sensitive eyes or compromised immune systems are at higher risk.
How to tell if you have this one
Check the product label for the lot numbers RL25G04 (expiring 07/2027) or RL2H02 (expiring 08/2027). The product is a 0.5 fl oz eye drop bottle with a hang tag.
- Brand
Insight Pharmaceuticals- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Ongoing- Distribution
Nationwide in the USA.
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0870-2026 | Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15; Lot #: RL25G02, RL25G03, RL25G04, Exp. Date Jul-27; RL25H02, RL25H03, RL25H04, Exp. Date Aug-27; RL25K01, RL25K02, RL25K03, RL25K04, Exp. Date Sep-27; RL25M01, RL25M02, RL25M03, RL25M04, Exp. Date Oct-27; RL25N01, RL25N02, RL25N04, Exp. Date Nov-27. | 2,356,248 bottles |
| D-0871-2026 | Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) with Hang Tag, 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15; Lot #: RL25G04, Exp. Date 07/2027; RL2H02, Exp. Date 08/2027. | — |
What to do — step by step
Stop Using the Drops
Discard the affected eye drops immediately to prevent potential eye infections.
Questions people ask
Are these eye drops safe to use?
The recall states there is a lack of assurance of sterility, so they may not be safe. Do not use the affected lots.
What should I do if I have the recalled product?
Discard the product immediately and contact Insight Pharmaceuticals for more information.
How can I check if my product is affected?
Check the lot number on the bottle; affected lots are RL25G04 (expiring 07/2027) or RL2H02 (expiring 08/2027).
Contact Insight Pharmaceuticals
We’ve drafted a message you can send Insight Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-0871-2026 — Insight Pharmaceuticals Insight Pharmaceuticals Hello, I own a Insight Pharmaceuticals that is covered by recall D-0871-2026 from Insight Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0871-2026 (September 15, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0871-2026 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.